BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Apellis Gains Momentum in Battle to Unseat Alexion in PNH with FDA Approval of Empaveli

  Empaveli (pegcetacoplan) is the first and only targeted C3 therapy for the treatment of adults with PNH, the Waltham, Mass.-based company said in its announcement.

  May 17, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  LianBio Partners With Landos to Commercialize Colitis, Crohn’s Drugs in China

  Landos Biopharma partnered with Shanghai, China-based LianBio to develop and commercialize omilancor and NX-13 in Greater China and select Asian markets.

  May 17, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Regeneron’s Evinacumab Reduces High Triglycerides but Stumbles in Genetic Subgroup

  A recent Phase II trial show Regeneron’s monoclonal antibody evinacumab significantly reduced fasting triglycerides in patients with severe hypertriglyceridemia.

  May 17, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Drug Development

  Incyte’s Ruxolitinib Cream Shows Promise for Vitiligo in Phase III Trials

  The use of ruxolitinib cream, Incyte’s investigational anti-inflammatory JAK inhibitor topical treatment, significantly improved facial vitiligo in adolescents and adults.

  May 17, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  BioCapital

  Biopharma Execs Address the Challenges of a Post-Pandemic Workplace

  If these companies are any indication, it appears that the biopharma industry will be a hybrid of virtual and physical workforces, and with this comes a whole new set of risks.

  May 17, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Business

  Vedere Bio is Bypassing What’s Broken to Create Light in Vision Loss

  The robust $77 million Series A was led by Octagon Capital and the leadership and research team behind the original Vedere Bio.

  May 17, 2021

   · 

  4 min read

   · 

  Heather McKenzie
• 

  Policy

  “Paradigm Shift” Needed in Air Purity to Reduce Spread of COVID-19, Study Says

  Researchers are calling for a “paradigm shift” in indoor ventilation systems to combat COVID-19 and other airborne pathogens.

  May 17, 2021

   · 

  4 min read

   · 

  Kate Goodwin
• 

  Drug Development

  Positive Phase II Results Show There’s Still Hope for the Sanofi/GSK COVID-19 Vaccine

  Sanofi and GSK expect to launch a global pivotal Phase III trial of its COVID-19 vaccine in the coming week.

  May 17, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  To Mask or Not to Mask: CDC Issues New Guidelines on Protective Facial Coverings

  New pandemic guidelines from the CDC nearly eliminates mask-wearing requirement for fully vaccinated people.

  May 17, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  FDA Issues Final Master Protocols Guidance for COVID-19 Drugs and Vaccines

  The guidance takes effect immediately and will remain in effect throughout the pandemic.

  May 17, 2021

   · 

  4 min read

   · 

  Gail Dutton